ArticleHemaSphere2026

Non-ICANS neurotoxicity after BCMA-directed CAR-T therapy: Clinical spectrum, outcomes, and a framework for neurology-oncology co-management.

Jan-Michael Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.